Coronavirus Update: Sanofi And GSK’s Vaccine Suffers Setback
Plus: Pfizer On Track In US, But Needs More Time In India
• By Scrip Team
The companies believe the vaccine could be authorized and ready for use by Q4 2021, approximately a six month delay to previous timelines. 
